Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial

OBJECTIVES: We evaluated the hypothesis that cyclooxygenase (COX) inhibitor use might have counteracted a beneficial effect of postmenopausal hormone therapy, and account for the absence of cardioprotection in the Women's Health Initiative hormone trials. Estrogen increases COX expression, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Judith, Manson, JoAnn E, Kuller, Lewis, Pettinger, Mary, Choe, John H, Langer, Robert D, Limacher, Marian, Oberman, Albert, Ockene, Judith, O'Sullivan, Mary Jo, Robinson, Jennifer G
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1584256/
https://www.ncbi.nlm.nih.gov/pubmed/17016543
http://dx.doi.org/10.1371/journal.pctr.0010026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1584256/
https://www.ncbi.nlm.nih.gov/pubmed/17016543
http://dx.doi.org/10.1371/journal.pctr.0010026

Ejemplares similares